The Union Budget 2025-26 strengthens India's healthcare sector with an allocation of Rs. 99,858.56 crore, marking a 9.78% rise from Rs. 90,958.63 crore in 2024-25
We now rank 3rd in pharmaceutical production by volume and 14th by value
The sales of medicines and other items sold through Jan Aushadhi Kendras have increased from Rs. 7.29 crore in 2014 to Rs. 1,470 crore by July 2024
Decision on EU marketing authorisation for this population expected by September 2024
GSK and Flagship to jointly fund up to $150 million upfront
The CALINA study tested a new ratio and dose of Coartem to account for metabolic differences in babies under 5 kg
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
Glenmark will be responsible for further developing, registering, and commercializing Envafolimab in India, Asia Pacific, Middle East and Africa, Russia, CIS, and Latin America
NPPA fixes the ceiling price of scheduled formulations as per the extant provisions of DPCO, 201
Commenced operations in flood-affected Himachal Pradesh
Subscribe To Our Newsletter & Stay Updated
